Validity and Reliability of the Modified Delirium Diagnostic Tool - Provisional (DDT-Pro) (Thai Version) in Peri-operative Fragility Hip Fracture Patient
1 other identifier
observational
110
1 country
1
Brief Summary
Nowadays, the number of hip fracture patients is increasing. As Thailand enters into an aging society, hip fractures are becoming more common. They are typically treated with surgery. Complications, such as urinary tract infections, pressure sores, and acute confusion, are often observed. These various complications contribute to an increased rate of illness and death. Delirium is a common problem among hip fracture patients. Currently, diagnosis is typically made using the Diagnostic and Statistical Manual of Mental Disorders (DSM-V), which is a standard tool. However, utilizing it effectively requires expertise. Additionally, other tools such as the Confusion Assessment Method (CAM) and the Memorial Delirium Assessment Scale (MDAS) are available. Nonetheless, training is necessary for their proper use, and they may be more suitable for specific patient groups. The Delirium Diagnostic Tool-Provisional (DDT-Pro) is another tool created to aid in diagnosing delirium. Unlike other tools, it does not require specialized training. It can assess the main symptoms of delirium, including cognitive ability, higher-level thinking skills, and the sleep-wake cycle. This tool has been utilized in foreign countries such as Spain. The tool was found to have good accuracy and reliability and is useful in aiding the diagnosis of delirium. However, it has never been translated and tested for use in elderly Thai patients with fragility hip fractures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 9, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 21, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 27, 2024
CompletedFirst Submitted
Initial submission to the registry
March 13, 2024
CompletedFirst Posted
Study publicly available on registry
July 16, 2024
CompletedSeptember 15, 2025
July 1, 2024
1.5 years
March 13, 2024
September 9, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
To evaluate the accuracy and reliability of the revised Thai language version of the Delirium Diagnostic Tool-Provisional (DDT-Pro).
Accuracy and reliability of the revised Thai language version of the Delirium Diagnostic Tool-Provisional (DDT-Pro) compared with the gold standard tool (DSM V)
3 day
Secondary Outcomes (1)
The incidence of delirium in patients with fragility hip fractures before and after surgical treatment.
3 day
Interventions
The Delirium Diagnostic Tool-Provisional (DDT-Pro) is another tool created to assist in the diagnosis of delirium. It does not require specialist expertise. It can assess the main symptoms of acute confusion, including cognitive ability (Cognition), higher-level thinking skills (Higher level thinking), and the sleep-wake cycle (Sleep-wake cycle).
Eligibility Criteria
The main objective of the study is to assess the validity and reliability (DDT-Pro) questionnaire in patients with fragility hip fractures before and after receiving surgical treatment. For evaluating the Concurrent validity of the tool: 1. Concurrent validity (95% Confidence Interval (CI) for the Area Under the Curve (AUC)) \- sample size = 99 2. For reliability assessment (Reliability) of the tool: 1. Internal consistency (95% confidence level for Cronbach's Alpha) \- sample size = 90 2. Inter-rater reliability (95% confidence interval for Kappa) - sample size = 66 Therefore, the sample size for analyzing inter-rater reliability is at least 66 cases, the sample size for analyzing internal consistency is at least 90 cases, and the sample size for concurrent validity analysis is at least 99 cases. However, the researcher expected a 10% dropout rate, so a sample size of at least 110 cases was used for the analysis.
You may qualify if:
- Patients older than 65 years
- Hip fracture within a period of 7 days
- Receiving treatment at Siriraj Hospital and who have undergone surgical treatment for the hip fracture.
You may not qualify if:
- Unable to communicate in Thai
- Was diagnosed with cancer before or during treatment for a hip fracture
- Have a history of schizophrenia
- Patients infected with COVID-19
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Siriraj hospital
Bangkok, Bangkoknoi, 10700, Thailand
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 13, 2024
First Posted
July 16, 2024
Study Start
September 9, 2022
Primary Completion
February 21, 2024
Study Completion
February 27, 2024
Last Updated
September 15, 2025
Record last verified: 2024-07